Detalhe da pesquisa
1.
Association between chronic kidney disease and cancer mortality: A report from the ALLHAT.
Clin Nephrol
; 87 (2017)(1): 11-20, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27900942
2.
Visit-to-Visit Variability of Blood Pressure and Coronary Heart Disease, Stroke, Heart Failure, and Mortality: A Cohort Study.
Ann Intern Med
; 163(5): 329-38, 2015 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26215765
3.
Pravastatin and cardiovascular outcomes stratified by baseline eGFR in the lipid- lowering component of ALLHAT.
Clin Nephrol
; 80(4): 235-48, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23816477
4.
Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Arch Intern Med
; 168(2): 207-17, 2008 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-18227370
5.
Progression of kidney disease in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin versus usual care: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Am J Kidney Dis
; 52(3): 412-24, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18676075
6.
Blood pressure control by drug group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
J Clin Hypertens (Greenwich)
; 10(10): 751-60, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19090876
7.
Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate.
Ann Intern Med
; 144(3): 172-80, 2006 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-16461961
8.
Association of 3 Different Antihypertensive Medications With Hip and Pelvic Fracture Risk in Older Adults: Secondary Analysis of a Randomized Clinical Trial.
JAMA Intern Med
; 177(1): 67-76, 2017 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27893045
9.
Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Arch Intern Med
; 165(12): 1401-9, 2005 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-15983290
10.
Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Arch Intern Med
; 165(8): 936-46, 2005 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-15851647